Live Breaking News & Updates on Unmet Social Needs

Stay updated with breaking news from Unmet social needs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Overview

Vanda Pharmaceuticals Inc. is a leading global
biopharmaceutical company focused on the development and commercialization of
innovative therapies to address high unmet medical needs and. | May 3, 2023 ....

United States , Apotex Inc , Megapharm Ltd , Delaware District Court , Apotex Corp , Vanda Pharmaceuticals Inc , Drug Administration , Medicaid Drug Rebate Program , Us Court , Exchange Commission , Public Health Service , Impax Laboratories , Amneal Pharmaceuticals Inc , Laboratories Private Limited , Teva Pharmaceuticals United States Inc , Us District Court , Pharmaceuticals Inc , Hour Sleep Wake Disorder , Smith Magenis Syndrome , New Drug Application , Federal Circuit , Abbreviated New Drug Application , Pharmaceuticals United States , Information Act , Risk Factors , Annual Report ,

Spruce Biosciences to Participate in May Investor Conferences

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today. | May 2, 2023 ....

Securities Life Sciences Conference , Spruce Biosciences Inc , Spruce Biosciences , Life Sciences Conference , Markets Global Healthcare Conference , Nc Stock Exchange , Press Release , Edical Sprb Us85209e1091 ,

AN2 Therapeutics to Present at JMP Securities Life Sciences Conference

AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that. | May 1, 2023 ....

New York , United States , Eric Easom , Therapeutics Inc , Securities Life Sciences Conference , Life Sciences , Life Sciences Conference , An2 Therapeutics , Nc Stock Exchange , Press Release , Nnounced Antx Us0373261058 ,

Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update

Regulatory News:

Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today. | April 28, 2023 ....

United States , Darren Lui , Aptorum Group Or We , Daptorum Group , Aptorum Group Cayman , Singapore Agency For Science , Holding Group , Aptorum Group Form , Aptorum Group Limited Nasdaq , Drug Administration , Yu Group , Regulatory News , Group Limited , Euronext Paris , Chief Executive Officer , Executive Director , Methicillin Resistant Staphylococcus , Pipeline Update , Methicillin Resistant Staphylococcus Aureus , Acute Bacterial Skin , Skin Structure Infections , Ordinary Shares , Ordinary Share , Aptorum Group Cayman Limited , Classb Ordinary Shares , Term Sheet ,

New Data from Interim Analysis of Verastem Oncology's RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society of Clinical Oncology Annual Meeting

Registration-Directed RAMP-201 Trial Designed to Address High Unmet Need in Low-Grade Serous Ovarian Cancer, a Unique and Distinct Type of Ovarian Cancer with Limited Treatment Options

. | April 26, 2023 ....

United States , Brian Stuglik , Susana Banerjee , Exchange Commission , Drug Administration , American Society Of Clinical Oncology , Chugai Pharmaceutical Co Ltd , Secura Bio Inc , Institute Of Cancer Research , Raf And Mek Program , Verastem Oncology , Poster Discussion Session , American Society , Clinical Oncology , Annual Meeting , Chief Executive Officer , Cancer Research , Royal Marsden , Gynecologic Cancer , Session Display Date , Discussion Session Date , Board Number , Low Grade Serous Ovarian Cancer , Breakthrough Therapy , Secura Bio , Annual Report ,